ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Madrigal Pharmaceuticals, Inc. ?
1
Positive results in Dec 25
- OPERATING CASH FLOW(Y) Highest at USD -189.55 MM
- NET PROFIT(HY) Higher at USD -169.99 MM
- INVENTORY TURNOVER RATIO(HY) Highest at 1.06 times
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 30.71%, its profits have risen by 44.8%
3
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -0.66% over the previous quarter and currently hold 3.78% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
4
Market Beating Performance
- The stock has generated a return of 30.71% in the last 1 year, much higher than market (S&P 500) returns of 17.78%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Madrigal Pharmaceuticals, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Madrigal Pharmaceuticals, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Madrigal Pharmaceuticals, Inc.
30.71%
1.46
48.07%
S&P 500
17.78%
0.92
19.35%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
294.82%
EBIT Growth (5y)
-11.34%
EBIT to Interest (avg)
-116.13
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.03
Sales to Capital Employed (avg)
0.44
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
14.09
EV to EBIT
-29.45
EV to EBITDA
-29.58
EV to Capital Employed
681.96
EV to Sales
17.70
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-2315.67%
ROE (Latest)
-40.50%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend25What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -189.55 MM
NET PROFIT(HY)
Higher at USD -169.99 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 1.06 times
NET SALES(Q)
Highest at USD 321.08 MM
CASH AND EQV(HY)
Highest at USD 2,103.4 MM
OPERATING PROFIT MARGIN(Q)
Highest at -18.44 %
-11What is not working for the Company
INTEREST(Q)
Highest at USD 8.3 MM
Here's what is working for Madrigal Pharmaceuticals, Inc.
Net Sales
At USD 321.08 MM has Grown at 210.77%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely positive
Net Sales (USD MM)
Net Sales
Highest at USD 321.08 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Net Profit
Higher at USD -169.99 MM
than preceding 12 month period ended Dec 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Inventory Turnover Ratio
Highest at 1.06 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Operating Cash Flow
Highest at USD -189.55 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Operating Profit Margin
Highest at -18.44 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Cash and Eqv
Highest at USD 2,103.4 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for Madrigal Pharmaceuticals, Inc.
Interest
At USD 8.3 MM has Grown at 11.35%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Interest
Highest at USD 8.3 MM
in the last five periods and Increased by 11.35% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
